Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Pain 1Neoplasms 1Inflammation 1Hypertension 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

palbociclib 2Ketorolac 2dapagliflozin 1Tablets 1Surgical Procedures, Operative 1Sulindac 1Specimen Handling 1Rivaroxaban 1Resistance Training 1Radiotherapy, Conformal 1Probiotics 1Pregabalin 1Plastic Surgery Procedures 1Omeprazole 1Neoadjuvant Therapy 1Methods 1Mastectomy 1Massage 1Losartan 1Ibuprofen 1Fish Oils 1Exercise 1Cognitive Behavioral Therapy 1Bevacizumab 1Art Therapy 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammation × Sulindac × Breast × Clear all
NCT01761877 2023-02-10

NSAID Effects on Clinical and Imaging Breast Biomarkers

Stony Brook University

Phase 2 Completed
114 enrolled 11 charts
Breast

Breast Neoplasms, Hypertension, Inflammation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡